Moxeza

What is Moxeza?[edit | edit source]

Moxeza (Moxifloxacin hydrochloride) used for the treatment of bacterial conjunctivitis.

Moxifloxacin skeletal

Moxifloxacin-cation-from-xtal-3D-balls

MOXEZA is used for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:

Moxifloxacin is a member of the fluoroquinolone class of anti-infective drugs.
The antibacterial action of moxifloxacin results from inhibition of the topoisomerase II (DNA gyrase) and topoisomerase IV.
DNA gyrase is an essential enzyme that is involved in the replication, transcription and repair of bacterial DNA.
Topoisomerase IV is an enzyme known to play a key role in the partitioning of the chromosomal DNA during bacterial cell division.

Moxifloxacin was approved for use in the United States in 1999 and is available generically and under the commercial names of Avelox, Moxeza and Vigamox.

Recommended dosage:

Administration:

Advise patients not to touch the dropper tip to any surface to avoid contaminating the contents.
Advise patients not to wear contact lenses if they have signs and symptoms of bacterial conjunctivitis.

This medicine is available in fallowing doasage form:

This medicine is available in fallowing brand namesː

The most common side effects of this medicine include:

MOXEZA will cause damage to the corneal endothelium if introduced directly into the anterior chamber of the eye.
Hypersensitivity and anaphylaxis have been reported with systemic use of moxifloxacin. Serious acute hypersensitivity reactions may require immediate emergency treatment. Oxygen and airway management should be administered as clinically indicated.
As with other anti-infectives, prolonged use may result in overgrowth of non-susceptible organisms, including fungi. If superinfection occurs, discontinue use and institute alternative therapy.
Patients should be advised not to wear contact lenses if they have signs or symptoms of bacterial conjunctivitis.

In case of overdose, call the poison control helpline of your country. In the United States, call 1-800-222-1222.

Overdose related information is also available online at poisonhelp.org/help.
In the event that the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services. In the United States, call 911.

There are no adequate and well-controlled studies with MOXEZA in pregnant women to inform any drug-associated risks.

The safety and effectiveness of MOXEZA in infants below 4 months of age have not been established.

Active ingredient:

Inactive ingredients:

Distributed by:

Moxeza Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.